Stockscreener 앱 받기
4.05
1.50%
0.06
시간 외 거래:
4.14
0.09
+2.22%
전일 마감가:
$3.99
열려 있는:
$4
하루 거래량:
564.21K
Relative Volume:
0.16
시가총액:
$12.82M
수익:
$129.20K
순이익/손실:
$-7.44M
주가수익비율:
-0.3619
EPS:
-11.19
순현금흐름:
$-8.62M
1주 성능:
-21.36%
1개월 성능:
+261.61%
6개월 성능:
+134.10%
1년 성능:
-41.13%
1일 변동 폭
$3.975
$4.38
1주일 범위
$3.83
$5.19
52주 변동 폭
$1.08
$19.30
Sonnet Biotherapeutics Holdings Inc Stock (SONN) Company Profile
명칭
Sonnet Biotherapeutics Holdings Inc
전화
609-375-2227
주소
100 OVERLOOK CENTER, PRINCETON, NJ
SONN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SONN
Sonnet Biotherapeutics Holdings Inc
|
4.05 | 24.99M | 129.20K | -7.44M | -8.62M | -11.19 |
|
VRTX
Vertex Pharmaceuticals Inc
|
460.83 | 120.60B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.63 | 60.80B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
324.79 | 42.87B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
595.19 | 36.23B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
294.51 | 31.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Sonnet Biotherapeutics Holdings Inc 주식(SONN)의 최신 뉴스
What is the risk reward ratio of investing in Sonnet BioTherapeutics Holdings Inc. stockCapitalize on trading strategies that deliver - jammulinksnews.com
Analyzing net buyer seller activity in Sonnet BioTherapeutics Holdings Inc.Insider Strategy for High Conviction Picks - Newser
Why is Sonnet BioTherapeutics Holdings Inc. stock attracting strong analyst attentionAchieve breakthrough profits with smart strategies - jammulinksnews.com
What institutional investors are buying Sonnet BioTherapeutics Holdings Inc. stockCapitalize on momentum-driven investment opportunities - jammulinksnews.com
What is the dividend policy of Sonnet BioTherapeutics Holdings Inc. stockUnlock exclusive stock market insights - jammulinksnews.com
Is Sonnet BioTherapeutics Holdings Inc. stock overvalued or undervaluedMaximize returns with strategic stock selection - jammulinksnews.com
How strong is Sonnet BioTherapeutics Holdings Inc. company’s balance sheetUncover the best stocks for explosive growth - jammulinksnews.com
Why Sonnet BioTherapeutics Holdings Inc. stock attracts strong analyst attentionHigh Return Potential - Newser
How Interest Rate Changes Impact Sonnet BioTherapeutics Holdings Inc. Stock PerformanceFree Access to Community - Newser
Top Risks to Consider Before Buying Sonnet BioTherapeutics Holdings Inc. StockFree Deep Market Trend Analysis - Newser
What drives Sonnet BioTherapeutics Holdings Inc. stock priceSuperior profit margins - PrintWeekIndia
Sonnet BioTherapeutics Holdings Inc. Stock Analysis and ForecastFree Stock Chart Pattern Guide - PrintWeekIndia
Is Sonnet BioTherapeutics Holdings Inc. a good long term investmentFree Capital Efficiency Planning - PrintWeekIndia
How Sonnet BioTherapeutics Holdings Inc. stock performs during market volatilityFree Market Analysis Group - Newser
What analysts say about Sonnet BioTherapeutics Holdings Inc. stockConsistently superior profits - jammulinksnews.com
Sonnet Announces the Passing of Founder and CEO Pankaj Mohan, Ph.D. - Yahoo.co
Halper Sadeh investigates Sonnet BioTherapeutics, First Community Corp, Monogram Technologies mergers. - AInvest
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SONN, FCCO, MGRM on Behalf of Shareholders - GlobeNewswire Inc.
Biotech Minnow Sonnet Takes A Hard Turn Into Crypto - Finimize
Sonnet BioTherapeutics Secures Funding to Meet Nasdaq Requirements - TipRanks
Sonnet BioTherapeutics Announces First Patient Dosed in Phase 1 Clinical Trial of SON-1010 for Advanced Solid Tumors - ACCESS Newswire
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
Sonnet BioTherapeutics Bets Big on HYPE Token as Charts Signal 161% Rally Potential - CoinChapter
Sonnet BioTherapeutics’ New Strategy with $888 Million Worth of Crypto Reserves! - Pintu
Sonnet BioTherapeutics Launches $583 Million Crypto Treasury With HYPE Token - AInvest
Hyperliquid Strategies Inc. plan for $583M treasury boosts HYPE price - Cointelegraph
Sonnet BioTherapeutics Announces $888M Combination With Rorschach For HYPE Treasury - Tekedia
Sonnet Biotherapeutics Holdings Inc (SONN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.32%
1.06%
자본화:
|
볼륨(24시간):